Cancer test scores $4m in capital for biotech
SYDNEY: Early-stage biotech BCAL Diagnostics has closed a $4 million pre-IPO capital raise ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
